Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: Review of the dermatologic and rheumatologic literature

被引：42

作者：

Dadlani, C ^{[1
]}

Orlow, SJ

机构：

[1] NYU, Sch Med, Dept Pediat, New York, NY USA

[2] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 02期

关键词：

D O I：

10.1016/j.jaad.2004.07.043

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：316 / 340

页数：25

共 49 条

[1]

Alli N, 1998, BRIT J DERMATOL, V139, P754

[2] Cyclosporine in severe childhood atopic dermatitis: A multicenter study [J].

BerthJones, J ;

Finlay, AY ;

Zaki, I ;

Tan, B ;

Goodyear, H ;

LewisJones, S ;

Cork, MJ ;

Bleehen, SS ;

Salek, MS ;

Allen, BR ;

Friedmann, P ;

Harper, J ;

Camp, RDR ;

Smith, S ;

GrahamBrown, RAC .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (06) :1016-1021

[3] METHOTREXATE AND PREDNISOLONE TREATMENT OF A CHILD WITH PSORIATIC ARTHRITIS [J].

BJORKSTEN, B ;

BACK, O .

ACTA PAEDIATRICA SCANDINAVICA, 1975, 64 (04) :664-666

[4] Effect of oral cyclosporin A in children with Staphylococcus aureus-colonized vs. S-aureus-infected severe atopic dermatitis [J].

Bunikowski, R ;

Mielke, M ;

Bräutigam, M ;

Renz, H ;

Wahn, U .

PEDIATRIC ALLERGY AND IMMUNOLOGY, 2003, 14 (01) :55-59

[5] Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis:: Clinical and immunological effects [J].

Bunikowski, R ;

Staab, D ;

Kussebi, F ;

Bräutigam, M ;

Weidinger, G ;

Renz, H ;

Wahn, U .

PEDIATRIC ALLERGY AND IMMUNOLOGY, 2001, 12 (04) :216-223

[6]

COHEN BA, 2000, PEDIAT DERMATOLOGY

[7] The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis [J].

Elkayam, O ;

Caspi, D ;

Reitblatt, T ;

Charboneau, D ;

Rubins, JB .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (04) :283-288

[8] International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies [J].

Ellis, C ;

Luger, T ;

Abeck, D ;

Allen, R ;

Graham-Brown, RAC ;

De Prost, Y ;

Eichenfield, LF ;

Ferrandiz, C ;

Giannetti, A ;

Hanifin, J ;

Koo, JYM ;

Leung, D ;

Lynde, C ;

Ring, J ;

Ruiz-Maldonado, R .

BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 :3-10

[9] Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept [J].

Elwood, RL ;

Pelszynski, MM ;

Corman, LI .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (03) :286-288

[10] Safety and efficacy of disease-modifying anti-rheumatic agents - Focus on the benefits and risks of etanercept [J].

Fleischmann, R ;

Iqbal, I ;

Nandeshwar, P ;

Quiceno, A .

DRUG SAFETY, 2002, 25 (03) :173-197

← 1 2 3 4 5 →